Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
993.8 DKK | -9.64% | -9.65% | -25.28% |
Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S